The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

Cytomegalovirus (CMV) infection is an important complication of solid-organ transplantation.
The availability of potent antiviral therapies has decreased the incidence of CMV disease …

Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …

Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation. Significant progress has been made in the …

Cytomegalovirus (CMV) is one of the most important pathogens that infect solid organ
transplant recipients. CMV is associated with increased morbidity and mortality in this …

Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …

This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid
organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV …

Cytomegalovirus is the classic opportunistic infection after solid organ transplantation. This
review will discuss updates and future directions in the diagnosis, prevention and treatment …

In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a common …